The confounding role of antimicrobial stewardship programs in understanding the impact of technology on patient care

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2420-2423

  Doern, Christopher D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP PROGRAM; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; ELECTRONIC MEDICAL RECORD; HEALTH PROGRAM; HOSPITAL COST; HUMAN; LENGTH OF STAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL INFORMATION; MORTALITY RATE; NOTE; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RAPID TEST; TREATMENT DURATION; TURNAROUND TIME;

ANTIINFECTIVE AGENT;

ANTI-INFECTIVE AGENTS; HUMANS; PATIENT CARE;

EID: 84991260338     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01484-16     Document Type: Note

References (18)

1. Kilpatrick ES, Holding S. 2001. Use of computer terminals on wards to access emergency test results: a retrospective audit. BMJ 322:1101-1103. http://dx.doi.org/10.1136/bmj.322.7294.1101.
2. Callen JL, Westbrook JI, Georgiou A, Li J. 2012. Failure to follow-up test results for ambulatory patients: a systematic review. J Gen Intern Med 27:1334-1348. http://dx.doi.org/10.1007/s11606-011-1949-5.
3. Barenfanger J, Drake C, Kacich G. 1999. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37:1415-1418.
4. Trenholme GM, Kaplan RL, Karakusis PH, Stine T, Fuhrer J, Landau W, Levin S. 1989. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 27:1342-1345.
5. Doern GV, Vautour R, Gaudet M, Levy B. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757-1762.
6. Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. 2008. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 52:3558-3563. http://dx.doi.org/10.1128/AAC.00283-08.
7. Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:3381-3383. http://dx.doi.org/10.1128/JCM.00751-06.
8. Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J, Patel T, Newton DW. 2014. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52:2849-2854. http://dx.doi.org/10.1128/JCM.00682-14.
9. Walker T, Dumadag S, Lee CJ, Lee SH, Bender JM, Cupo Abbott J, She RC. 2016. Clinical impact of laboratory implementation of Verigene BC-GN microarray-based assay for detection of Gram-negative bacteria in positive blood cultures. J Clin Microbiol 54:1789-1796. http://dx.doi.org/10.1128/JCM.00376-16.
10. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 51:1074-1080. http://dx.doi.org/10.1086/656623.
11. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM. 2014. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 69:216-225. http://dx.doi.org/10.1016/j.jinf.2014.05.005.
12. Sango A, McCarter YS, Johnson D, Ferreira J, Guzman N, Jankowski CA. 2013. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol 51:4008-4011. http://dx.doi.org/10.1128/JCM.01951-13.
13. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM. 2013. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:1247-1254. http://dx.doi.org/10.5858/arpa.2012-0651-OA.
14. Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R. 2015. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071-1080. http://dx.doi.org/10.1093/cid/civ447.
15. Doern GV, Scott DR, Rashad AL. 1982. Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 21:1023-1024. http://dx.doi.org/10.1128/AAC.21.6.1023.
16. Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA, Verhulst SJ, Peterson R, Moja LB, Ertmoed MM, Moja AB, Shevlin DW, Vautrain R, Callahan CD. 2008. Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol 130:870-876. http://dx.doi.org/10.1309/AJCPVMDQU2ZJDPBL.
17. MacVane SH, Nolte FS. 2016. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54:2476-2484. http://dx.doi.org/10.1128/JCM.00996-16.
18. Doern GV. 2014. The value of outcomes data in the practice of clinical microbiology. J Clin Microbiol 52:1314-1316. http://dx.doi.org/10.1128/JCM.00712-14.